title: Inhibitors of hepatic microsomal triacylglycerol hydrolase decrease very low density lipoprotein secretion.
abstract: The presence of elevated circulating triacylglycerol (TG)-rich very low density lipoprotein (VLDL) and apolipoprotein B-100 (apoB-100) levels represents an independent risk factor for coronary artery disease. Triacylglycerol hydrolase catalyzes the mobilization of cytoplasmic TG stores. To test the hypothesis that the enzyme plays a role in the provision of core lipids for the assembly of VLDL, we inhibited the lipase activity in primary rat hepatocytes and analyzed lipid and apoB synthesis and secretion. Inhibition of lipolysis resulted in a dramatic decrease in secretion of TGs. In addition, secretion of cholesteryl ester and phosphatidylcholine was substantially decreased. Analysis of secreted apolipoproteins indicated that apoB-100 secretion was much more sensitive to lipase inhibition than was apoB-48 secretion, perhaps because of the ability of apoB-48 to be secreted as a relatively lipid-poor particle. The results agreed with those obtained with hepatoma cells transfected with triacylglycerol hydrolase cDNA, in which preferential lipidation of apoB-100 was observed. Together, our findings provide evidence that inhibition of intracellular TG hydrolysis significantly decreases apoB-100 secretion and suggest that triacylglycerol hydrolase may be a suitable pharmacological target in efforts to lower plasma lipid levels.
authors.affiliation: Department of Cell Biology, CIHR Group on the Molecular and Cell Biology of Lipids, University of Alberta, Edmonton, Alberta, Canada T6G 2S2.
authors.forename: Dean
authors.initials: D
authors.lastname: Gilham
authors.forename: Samuel
authors.initials: S
authors.lastname: Ho
authors.forename: Mehdi
authors.initials: M
authors.lastname: Rasouli
authors.forename: Paul
authors.initials: P
authors.lastname: Martres
authors.forename: Dennis E
authors.initials: DE
authors.lastname: Vance
authors.forename: Richard
authors.initials: R
authors.lastname: Lehner
mesh_terms: D000818:Animals; D001055:Apolipoproteins B / Q000096:biosynthesis; D002478:Cells, Cultured; D004791:Enzyme Inhibitors / Q000494:pharmacology; D022781:Hepatocytes / Q000187:drug effects / Q000201:enzymology* / Q000378:metabolism; D008049:Lipase / Q000037:antagonists & inhibitors*; D050356:Lipid Metabolism; D008079:Lipoproteins, VLDL / Q000378:metabolism*; D008862:Microsomes, Liver / Q000201:enzymology; D008954:Models, Biological; D010261:Paraoxon / Q000494:pharmacology; D051381:Rats
chemical_list: D001055:Apolipoproteins B; D004791:Enzyme Inhibitors; D008079:Lipoproteins, VLDL; D008049:Lipase; D010261:Paraoxon